Posted by Michael Wonder on 23 Oct 2023
1 November 2023 changes to the PBS listings of medicines for children and adolescents with chronic plaque psoriasis
23 October 2023 - On 1 November 2023, changes will be made to the authority requirements of the PBS listing for etanercept for the treatment of children and adolescents with severe chronic plaque psoriasis.
From this date, the PBS listings of etanercept for initial therapy will change from Authority Required (Written), to Authority Required (telephone/immediate online assessment). The PBS listings to complete a course of treatment will change to Authority Required (Streamlined).
